Filter
4044
Text search:
new
HIV
infections
Featured
366
1157
Language
Document type
2657
480
455
144
108
87
55
31
19
3
2
2
1
Countries
187
150
106
98
94
94
92
91
90
89
82
82
79
70
60
57
56
54
54
52
47
45
43
38
33
33
31
29
29
29
23
23
23
23
21
18
18
18
17
15
15
15
13
13
13
12
11
10
10
9
8
8
8
7
7
7
6
6
5
5
5
5
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
1709
367
269
147
96
95
44
3
Toolboxes
826
288
191
142
100
95
73
65
61
60
58
52
43
42
34
27
25
23
16
13
10
5
4
1
1
A Booklet on Women and HIV/AIDS for Auxiliary Nurse Midwives (ANMs) Accredited Social Health Activists (ASHAs) Anganwadi Workers (AWWs) and Members of Self-help Groups (SHGs)
Version 2
Version 2
Advance copy.
Accessed online August 2018
Country Progress Report January 2008 - December 2009
Reporting Period 2010-2011
The five thematic discussion papers in this collection were prepared by members of the Global Prevention Coalition Steering Group and other experts from various institutions and countries. Contributors are listed in alphabetical order. The five papers are meant to inform country consultations and th
...
National Tuberculosis Control Program; Mycobacterial Disease Control National AIDS/STD Program
July 2022
WPSAR Vol 8, No 4, 2017 | doi: 10.5365/wpsar.2017.8.3.005
DOI: http://dx.doi.org/10.5365/wpsar.v8i4.564
Journal of Virus Eradication 2016; 2 (Supplement 4): 1–6
Review
Joint Action for Results
UNAIDS Outcome Framework: Business Case 2009–2011
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0169530 February 16, 2017
(pop. 621 240)
Evaluation report
September 2014
(pop. 45 782 592)
Recommendations for a Public Health approach and considerations for policy-makers and managers
HIV Diagnostics
Information Note
WHO/HIV/2017.16
UNICEF’s Global HIV Response 2018 – 2021
Accessed: 02.11.2019
Technical Paper
Consolidated Guidelines
Geneva, 2016
The End TB Strategy
Joint Action for Results
UNAIDS Outcome Framework: Business Case 2009–2011
Education on the move
Technical Report
AIDS Medicines and diagnostics service
July 2015
“Continuum of HIV services refers to a comprehensive package of HIV prevention, diagnostic, treatment, care and support services provided for people at risk of
...
Guidelines
HIV testing services
July 2015
Participant Manual September 2009
The COVID-19 pandemic has exposed the inadequacy of investments in public health, the persistence of profound economic and social inequalities and the fragility of many key global systems and approaches.
This fourth progress report November 2020 of the Global HIV Prevention Coalition reviews the progress in the 28 focus countries and complements the three previous progress reports. This report describes key developments in 2019–2020, identifies ch
...
This publication provides managers with guidance on how to create basic HIV prevention cascades as a starting point to enhance their ability to monitor and improve their programming and to facilitate comparisons of programme effectiveness across sit
...
Human Papilloma Virus (HPV) is the most common sexually transmitted infection, and two types of HPV (16 and 18) cause nearly 50% of high-grade cervical pre-cancers. HIV and cervical cancer are inextricably linked. Women living with
...
Training for Health Care Providers
Facilitators’ Manual
Guidelines for national programmes and other stakeholders
世界卫生组织 结核菌/艾滋病病毒双 重感染防治政策指南
——适用于国家规划 和利益攸关方
Meeting Report
Bangkok, Thailand 8-11 August 2016
Accessed: 03.09.2019
Child Survival Working Group
Accessed: 26.10.2019
Technical Report
International Journal of Infectious Diseases 80 (2019) 10–15
journal homepage: www.elsevier.com/locate/ijid
2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
Guidelines for national programmes and other stakeholders, for annexes see http://www.who.int/tb/publications/2012/tb_hiv_policy_9789241503006/en/
Joint WHO/ILO guidelines on post-exposure prophylaxis (PEP) to prevent HIV infection.
Topics in Antiviral Medicine 25 Issue 2 May/June 2017
Article, January 2008
braz j infect dis. 2014;18(5):491–495
http://dx.doi.org/10.1016/j.bjid.2014.02.004
1413-8670/© 2014 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
Policy Brief
Accessed: 20.11.2019
Accessed: 20.11.2019
HIV & AIDS Treatment in Practice No.199
Manual for Trainers and Programme Managers
The revised guidelines present two major changes to existing guidelines: (A) there are now just 2 categories of pneumonia instead of 3 (“pneumonia” which is treated at home with oral amoxicillin and “severe pneumonia” which requires injectable antibiotics) and (B) oral amoxicillin replaces o
...
PLoS One. 2012; 7(4): e29656.
Published online 2012 Apr 20. doi: 10.1371/journal.pone.0029656
Where There Is No Doctor. New Chapters
recommended
Advance chapters from the new edition
WHO/HTM/HIV/2007.01 WHO/HTM/TB/2007.380
Time for recognition of lay counsellors
Accessed November 2017
The Open Infectious Diseases Journal, 2010, 4, 33-37
Practical Guideline for collaborative interventions
HIV testing
Policy Brief
July 2015
UNAIDS 2017 | Explainer
Standard Treatment Guidelines
UNAIDS/WHO Working group
HIV/AIDS and STI surveillance 2015 / Reference
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for
...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care.
...
This report provides an analysis of donor government funding to address the HIV response in low- and
middle-income countries in 2022, the latest year available, as well as trends over time. It includes both
bilateral funding from donors and their
...
Provide guidance to HIV care practitioners on the optimal use of antiretroviral (ARV) agents for the treatment of HIV infection in adults and adolescents.